Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ITRACONAZOLE for Dermatitis: Side Effects & Safety Data

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

There are 12 adverse event reports in the FDA FAERS database where ITRACONAZOLE was used for Dermatitis.

Most Reported Side Effects for ITRACONAZOLE

Side Effect Reports % Deaths Hosp.
Drug ineffective 560 14.0% 136 152
Drug interaction 418 10.4% 22 154
Off label use 268 6.7% 43 101
Condition aggravated 193 4.8% 55 113
Dyspnoea 188 4.7% 53 129
Nausea 153 3.8% 4 62
Drug resistance 152 3.8% 27 27
Rash 125 3.1% 17 50
Hypertension 117 2.9% 8 26
Diarrhoea 114 2.8% 19 41
Hospitalisation 110 2.7% 0 110
Product use in unapproved indication 110 2.7% 29 32
Pyrexia 110 2.7% 26 58
Fatigue 100 2.5% 6 55
Cough 96 2.4% 4 49

Other Indications for ITRACONAZOLE

Product used for unknown indication (870) Bronchopulmonary aspergillosis (293) Antifungal prophylaxis (207) Aspergillus infection (197) Fungal infection (190) Onychomycosis (171) Histoplasmosis (167) Prophylaxis (129) Bronchopulmonary aspergillosis allergic (111) Histoplasmosis disseminated (101)

Other Drugs Used for Dermatitis

DUPILUMAB (9,959) CRISABOROLE (407) APREMILAST (122) TRALOKINUMAB-LDRM (90) KETOCONAZOLE (66) CYCLOSPORINE (62) DOXYCYCLINE (57) PIMECROLIMUS (55) CLOBETASOL (50) RUXOLITINIB (50)

Related Pages

ITRACONAZOLE Full Profile All Dermatitis Drugs ITRACONAZOLE Demographics ITRACONAZOLE Timeline